Experimental studies on potentiation of the antitumor activity of 5-fluorouracil with 3'-azido-3'-deoxythymidine for the gastric cancer cell line MKN28 in vivo

Japanese Journal of Cancer Research

Volumn 88, Issue 1, 1997, Pages 97-102

  Yasuda, Chikao ^a   Kato, Michio ^a   Kuroda, Daisuke ^a   Ohyanagi, Harumasa ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

3' azido 3 deoxythymidine; 5 fluorouracil; Biochemical modulation; Gastric cancer; Prevention of DNA synthesis

Indexed keywords

BROXURIDINE; FLUOROURACIL; THYMIDYLATE SYNTHASE; ZIDOVUDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER TRANSPLANTATION; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; STOMACH CANCER;

EID: 0031050387     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1997.tb00307.x     Document Type: Article

References (24)

1. Petrelli, N. J., Madajewicz, S., Herrera, L., Rustum, Y. M., Trave, F., Creaven, P. and Mittelman, A. Biologic modulation of 5-fluorouracil with high-dose leucovorin and combination chemotherapy of 5-fluorouracil and cisplatin in metastatic colorectal adenocarcinoma. Ned. Chem. Ind. Monogr., 5, 189-192 (1987).
2. Weber, G. Biochemical strategy of cancer cells and the design of chemotherapy: GHA Clowes Memorial Lecture. Cancer Res., 43, 3466-3492 (1983).
3. Spiegelman, S., Nayak, R., Sawyer, R., Stolfi, R. and Martin, D. Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU) RNA. Cancer, 45, 1129-1134 (1980).7
4. Brunetti, I., Falcone, A., Calabresi, P., Goulette, F. A. and Darnowski, J. W. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies, Cancer Res., 50, 4026-4031(1990).
5. Unadkat, J. D., Wang, J. P., Pulham, D. and Semmes, R. L. O. Dose-ranging pharmacokinetics of zidovudine (azidothymidine) in the rat. Pharm. Res., 6, 734-736 (1989)
6. Spears, C. P., Shahinian, A. H., Moran, R. G., Heiderberger, C. and Corbett, T. H. In vivo kinetics of thymidylate synthetase inhibition in 5-fluorouracilsensitive and -resistant murine colon adenocarcinomas. Cancer Res., 42, 450-456 (1982).
7. Taylor, A. Jr., Hewitt, E. G. and Jones, O. W. Tumor- associated thymidine kinase in the sera of rats with transplanted hepatomas. Cancer Res., 36, 2070-2072 (1976).
8. Masuike, T., Watanabe, I. and Takemoto, Y. Quantitative method of 5-fluorouracil and its metabolites in biological samples using high performance liquid chromatography. J. Pharm. Soc. Jpn., 105, 1058-1064 (1985), in Japanese.
9. Gratzner, H. G. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science, 218, 474-475 (1982).
10. Sasaki, K., Ogino, T. and Takahashi, M. Immunological determination of labeling index on human tumor tissue sections using monoclonal anti-BrdU antibody. Stain Technol., 66, 155-161 (1986).
11. Scanlon, K. J., Newman, E. M., Lu, Y. and Priest, D. G. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc, Natl. Acad, Sci. USA, 83, 8923-8925 (1986).
12. Kish, J., Drelichman, A., Jacobs, J., Hoschner, J., Kinzie, J., Loh, J., Weaver, A. and Al-Sarraf, M. Clinical trial of cisplatin and 5-FU infusion as initial teatment for advanced squamous cell carcinoma of the head and neck. Cancer Treat. Rep., 66, 471-474 (1982).
13. Evans, R. M., Laskin, J. D. and Hakala, M. T. Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil. Cancer Res., 41, 3288-3295 (1981).
14. Machover, D., Goldschmidt, E., Chollet, P., Metzger, G., Zittoun, J., Marquet, J., Vandenbulcke, J.-M., Misset, J.L., Schwarzenberg, L., Fourtillan, J. B., Gaget, H. and Mathe, G. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J. Clin. Oncol., 4, 685-696 (1986).
15. Bertino, J. R., Sawicki, W. L., Lindquist, C. A. and Gupta, V. S. Schedule-dependent antitumor effects of methotrexate and 5-fluorouracil. Cancer Res., 37, 321-328 (1977).
16. Bertino, J. R., Mini, E. and Fernandes, D. J. Sequential methotrexate and 5-fluorouracil: mechanisms of synergy. Semin. Oncol., 10 (Suppl. 2), 2-5 (1983).
17. Vogel, S. J., Presant, C. A., Ratkin, G. A. and Klahr, C. Phase I study of thymidine plus 5-fluorouracil infusions in advanced colorectal carcinoma. Cancer Treat. Rep., 63, 1-5 (1979).
18. Grem, J. L. and Fischer, P. H. Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole. Cancer Res., 45, 2967-2972 (1985).
19. Mitsuya, H., Weinhold, K. J., Furman, P. A., St. Clair, M. H., Lehrman, S. N., Gallo, R. C., Bolognesi, D., Barry, D. W. and Broder, S. 3′-Azido-3′-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/ lymphadenopathy-associated virus in vitro. Proc. Natl Acad. Sci. USA, 82, 7096-7100 (1985).
20. Furman, P. A., Fyfe, J. A., St. Clair, M. H., Weinhold, K., Rideout, J. L., Freeman, G. A., Lehrman, S. N., Bolognesi, D. P., Broder, S., Mitsuya, H. and Barry, D. W. Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc. Natl Acad. Sci. USA, 83, 8333-8337 (1986).
21. Weber, G., Nagai, M., Prajda, N., Nakamura, H., Szekeres, T. and Olah, E. AZT: a biochemical response modifier of methotrexate and 5-fluorouracil cytotoxicity in human ovarian and pancreatic carcinoma cells. Cancer Commun., 3, 127-132 (1991).
22. Sano, K., Sato, F., Hoshino, T. and Nagai, M. Experimental and clinical studies of radiosensitizers in brain tumors, with special reference to BUdR-antimetabolite continuous regional infusion-radiation therapy (BAR therapy). NeuroL Med, Chir., 7, 51-72 (1965).
23. Smith, L. H., Jr. Pyrimidine metabolism in man. N. Engl. J. Med., 288, 764-771 (1973).
24. Nord, L. D. and Martin, S. D. Loss of murine tumor thymidine kinase activity in vivo following 5-fluorouracil (FUra) treatment by incorporation of FUra into RNA. Biochem. Pharmacol., 42, 2369-2375 (1991).